Word: merck
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...spread and kill--if you do get cancer. Should you take it? That's the question doctors and patients have been wrestling with since the results of a National Cancer Institute--sponsored trial were published last week in the New England Journal of Medicine. Compared with a placebo, Merck's finasteride--a drug currently marketed to treat baldness and benign prostate enlargement--appeared to reduce prostate cancer incidence 25%. But in the seven-year study, involving more than 9,000 men ages 55 and older, the finasteride group also had a slightly higher rate of aggressive, "high grade" tumors, which...
...aids is being fueled by a bizarre and peculiarly American alliance. Where else could an aggressively self-confident and largely gay activist community find common purpose with the Christian right? Different aspects of the bill reflect the concerns of such disparate groupings as Act Up, the Abstinence Clearinghouse, drugmaker Merck and Co. and the Catholic Medical Mission Board. The aids consensus came about in part because scripture readings with Bono and the grassroots take-up of the Jubilee movement for debt relief have helped change the religious right's take on aids in the developing world: what was once seen...
...Vagelos is currently the Chair of the Board of Trustees of the University of Pennsylvania. Vagelos served as the Chief Executive Officer of the pharmaceutical firm Merck & Co. from 1985 to 1994, where he became known for his leadership ability...
...effects. The FDA has approved Deramaxx, the first animal drug to target the COX-2 enzyme, responsible for arthritic pain, while sparing the COX-1 enzyme, which helps dogs (and people) protect their stomach linings. This relief method puts Deramaxx in the same class as Celebrex (Pfizer) and Vioxx (Merck), which are for humans. Vets expect Deramaxx to cut into sales of Pfizer's Rimadyl and Wyeth's EtoGesic, which dominate the $150 million U.S. dog-arthritis market. Deramaxx will cost about $30 a month. Novartis plans to release it soon worldwide...
SAFE HAVENS Dividend-paying stocks like drugmakers Merck and Schering-Plough and utilities (Consolidated Edison, Southern Co.) should do well as investors tiptoe back into the safest stocks they can think of. Consider a yield-oriented stock fund like T. Rowe Price Capital Appreciation, which recently yielded 2% and gained 11% annually the past three years. If things go poorly for the U.S. in Iraq or elsewhere, this at least will provide some cushion and keep you in the game...